AAAmy Amuquandoh

Amy Amuquandoh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Amy Amuquandoh has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Evaluating pregnant women’s selenium intake through dietary assessment in Accra, Ghana: a feasibility study

    by Amy Amuquandoh, Marie Aluko, Ofori-Attah Ebenezer, Godfred Egbi, Kwame Adu-Bonsaffoh

    Objective Dietary selenium (Se) deficiency is associated adverse pregnancy outcomes. We sought to determine the feasibility of: (1) assessing dietary Se consumption via administration of a food frequency questionnaire (FFQ) to pregnant women attending the antenatal clinic of Korle Bu Teaching Hospital (KBTH) in Accra, Ghana and (2) quantifying total Se intake. Methods In this prospective observational cohort study, participants were recruited via purposive sampling and face-to-face data collection was undertaken using structured FFQs. English-speaking pregnant women who were ≥ 18 years old were eligible to participate. Questions of feasibility were assessed and the average total Se intake in the population was analyzed. Results One hundred study participants met the inclusion criteria out of 117 eligible. It was feasible to administer the surveys in the clinic waiting room. The average total Se intake in this population of pregnant women was 90.4 μg/day ±50.0 μg, which is higher than the National Institute of Health recommended dietary allowance (RDA) of 60μg/day for pregnant women. Conclusion FFQ assessment of Se consumption and resource evaluation were deemed feasible in the KBTH setting. Participants reported an average Se intake above the RDA. Future studies can examine the influence of Se intake on pregnancy outcomes.

  • Open Access

    Challenges and Proven Recommendations of Praziquantel Formulation

    by Deryl Nii Okantey Kuevi, Francis Asiedu Acquah, Amy Amuquandoh, Andrew Papa Abbey

    Background. Schistosomiasis, ranked second to malaria as one of the crucial parasitic infections in the world, infects close to 240 million people as at 2019. Praziquantel, an oral anthelmintic, is the first‐line drug for the treatment of schistosomiasis. Although the drug is safe and effective, the formulated tablets come with some limitations such as low bioavailability and bitter taste. This literature review aims to provide information on how to improve the issues of solubility, low bioavailability, and bitter taste associated with the praziquantel formulation and, subsequently, to be helpful in improving patient’s compliance. Materials and Methods. For gathering all pertinent data in this review on improving the praziquantel formulation, the following databases were used: Google Scholar, Science Direct, Scopus, PubMed, Springer Link, Elsevier, and Wiley online library. Results. Literature revealed that in improving the bioavailability of praziquantel, loading the drug with hydrogenated castor oil solid lipid nanoparticles has shown to be effective in prolonging systemic circulation from 7.6 to 95.9 hours after oral administration. Moreover, employing the solid dispersion technique using the fusion method increases the bioavailability of praziquantel about twice as much. Furthermore, incorporating a superdisintegrant or more than one disintegrant to the formulation can enhance the release of praziquantel. The addition of hydroxypropyl‐beta‐cyclodextrin (HP‐β‐CD) and sucralose as sweeteners can mask the bitter taste of praziquantel. Conclusion. The formulation approaches outlined in this review can be employed to greatly enhance the solubility, bioavailability, and taste of praziquantel. Although several techniques to improve praziquantel formulation have been widely studied, further studies on the release profile and compatibility studies with other excipients need to be investigated.


  • Exploring the spatial relationship between primary road distance to antenatal clinics and HIV prevalence in pregnant females of Lilongwe, Malawi

    by Amy Amuquandoh, Veronica Escamilla, Innocent Mofolo, Nora E Rosenberg

    While urbanization in a sub-Saharan African (SSA) context can lead to greater independence in women, various sociological, biological, and geographical factors in urban areas may keep women at a higher risk for HIV than men. Access to major roads during Malawi’s transition into rapid urbanization may leave women disproportionately vulnerable to HIV infection. It is not well established whether women who report to health clinics closer to major roads have higher or lower levels of HIV. In this study we explored the spatial heterogeneity of HIV prevalence among pregnant females in Lilongwe District, Malawi. Using Geographic Information Systems, we visually represented patterns of HIV prevalence in relation to primary roads. HIV prevalence data for 2015 were obtained from 44 antenatal clinics (ANC) in Lilongwe District. ANC prevalence data were aggregated to the administrative area and mapped. Euclidean distance between clinics and two primary roads that run through Lilongwe District were measured. A correlation was run to assess the relationship between area-level ANC HIV prevalence and clinic distance to the nearest primary road. ANC HIV prevalence ranged from 0% to 10.3%. Clinic to major road distance ranged from 0.1 to 35 km. Correlation results (r= −0.622, p = 0.002) revealed a significant negative relationship between clinic distance to primary road and HIV prevalence, indicating that the farther the clinics stood from primary roads, the lower the reported antenatal HIV prevalence. Overall, the clinic catchments through which the major roads run reported higher ANC HIV prevalence. Antenatal HIV prevalence decreases as ANC distance from primary roads increases in Lilongwe, Malawi. As urbanization continues to grow in this region, road distance may serve as a good indicator of HIV burden and help to guide targeted prevention and treatment efforts.